WO2005081704A2 - Sinus tarsi implant - Google Patents
Sinus tarsi implant Download PDFInfo
- Publication number
- WO2005081704A2 WO2005081704A2 PCT/US2004/036557 US2004036557W WO2005081704A2 WO 2005081704 A2 WO2005081704 A2 WO 2005081704A2 US 2004036557 W US2004036557 W US 2004036557W WO 2005081704 A2 WO2005081704 A2 WO 2005081704A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- implant
- patient
- sinus tarsi
- sinus
- tarsi
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/42—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
- A61F2/4225—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for feet, e.g. toes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B17/562—Implants for placement in joint gaps without restricting joint motion, e.g. to reduce arthritic pain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/42—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes
- A61F2/4202—Joints for wrists or ankles; for hands, e.g. fingers; for feet, e.g. toes for ankles
- A61F2002/4223—Implants for correcting a flat foot
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S606/00—Surgery
- Y10S606/907—Composed of particular material or coated
- Y10S606/91—Polymer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S606/00—Surgery
- Y10S606/916—Tool for installing or removing orthopedic fastener
Definitions
- This invention relates to a medical apparatus for enhancing and for correcting skeletal mechanics. More specifically, this invention relates to the correction of certain bone alignment deformities that impair optimal biped mechanics.
- Excessive pronation is caused by abnormal motion between two bones of the foot; the ankle bone (talus) and the heel bone (calcaneus). This abnormal motion will eventually lead to anatomical mal-alignment both proximally and distally. The abnormal motion is due to obliteration or closure of a naturally occurring space (sinus) formed between the talus and calcaneus.
- This sinus is referred to anatomically as the sinus tarsi. In anatomical terms, the sinus tarsi is located anterior to the subtalar joint and posterior to the talocalcaneo-navicular joint.
- the subtalar joint is formed by the posterior talar facet of the calcaneus and the posterior calcaneal facet of the talus.
- the talocalcaneonavicular joint is formed by the middle and anterior calcaneal facet of the talus and middle and anterior talar facet of the calcaneus.
- Hyperpronation is defined by excessive talar deviation medially (inward), anteriorly (forward), and plantarly (inferiorly).
- Hyperpronation is detected and diagnosed through physical examination of the foot, both non-weight bearing and weight bearing examination, as well as radiographic evaluation of the foot.
- Non-weight bearing examination of hyperpronation is achieved by applying pressure to the fifth metatarsal head region of the foot to dorsiflex the foot (push the foot toward the front of the shin) and if the foot turns out-ward hyperpronation is present.
- the person stands on his/her feet and the examiner observes both pronation and supination of the subtalar joint. Normally the foot should be in a "neutral" position, that is, neither pronated nor supinated. If the foot is in a pronated position while full weight is on the foot, the foot is considered hyperpronated.
- Radiographic evaluation of hyperpronation is seen by examining the weight-bearing anterior-posterior (top to bottom) view and the lateral (side) view. These two projections show the relationship of the talus to the other foot bones. If the talus is medially (inward) and/or anteriorly (forward) deviated and/or plantarflexed (inferiorly) displaced hyperpronation is present.
- Previous implants have been designed for insertion into the sinus tarsi in an attempt to treat foot disorders. In this, one envisioned design included a mushroom-shaped implant with a stem protruding from the bottom. The implant was held in place by inserting the stem into a hole drilled into the dorsum of the calcaneus.
- an implant is threaded on an outer surface and screwed into the sinus tarsi.
- This implant is usually composed of high molecular weight polyethylene.
- this device can only be gas sterilized. This allowed the device to deform under the compressive pressure to which it is subjected under normal post-operative condition. Furthermore, it was difficult to accurately locate the device properly within the sinus tarsi.
- a cylindrical implant made of a titanium alloy is threaded on an outer surface.
- this implant only corrects one portion of the deformity while both the lateral and medial portions of the sinus tarsi need correction.
- a titanium implant is much harder than surrounding bone matter. This can lead to bone wear and/or deformation.
- fluoroscopy is required in order to verify the position which exposes a patient to radiation. The procedure for insertion requires two separate incisions on the medial and lateral aspect of the foot and calls for a below-the-knee cast for two weeks post- operatively.
- the implant is made available in a series of sizes. These implants vary in size, one from the next, by specific increments. Gaps in this series can lead to under and over correction.
- An object of the invention is to insure proper foot motion by stabilizing the motion between the talus and calcaneus.
- Another object of the invention is to block hyperpronation between the talus and calcaneus while allowing normal foot motion.
- a further object of this invention is to correct mal-alignment, both proximally and distally, of the talus and calcaneus.
- Another object of the invention is to provide an implant that will not, over time, wear or deform the talus and calcaneus.
- Still another object of the invention is to provide an implant that will not wear or deform over time and thus fail.
- Another object is to provide an implant that will remain in place without a separate anchoring procedure.
- Another object of the invention is a method of correctly positioning an implant in the space between the talus and calcaneus bones without having to verify the correct position with a fluoroscope and thus expose the user to radiation.
- a further object of the invention is to provide less invasive surgery for inserting an implant.
- a related object of the invention it to provide a sinus tarsi implant without requiring a post-operative below-the-knee cast.
- An embodiment of the present invention that is intended to accomplish at least some of the foregoing objects comprises blocking motion of the subtalar joint with an internally placed orthotic device.
- this embodiment comprises a subtalar arthroeresis endorthosis implantation system.
- the implant is termed a subtalar or, more specifically, a sinus tarsi arthroeresis which maintains the sinus tarsi in an anatomically correct alignment, allowing the normal physiological motion to occur while minimizing a tendency for abnormal pre-operative motion.
- the sinus tarsi implant of the subject invention is generally funnel shaped or tapered and fits into the sinus tarsi.
- the implant comprises a frustum of a right cone portion as well as an integral extension.
- the frustum portion is considered the superficial or lateral portion of the implant and may be operably positioned within the lateral or sinus region of the sinus tarsi.
- a small diameter cylindrical portion of the implant is considered the medial side of the implant and will be operably positioned within a deeper side of the sinus tarsi, the canalis tarsi.
- the surface of the implant optionally contains channels or a roughened texture in selected regions. These surface regions will, in a preferred embodiment, interact with the surrounding tissue. This interaction increases the mechanical retention between the surface of implant and the surrounding tissue and thus helps maintain the implant in a proper anatomical position.
- the sinus tarsi implant of the subject invention is preferably constructed of a medical grade polymer.
- the polymer composition will allow for less trauma to the external bone surface as compared to a metal alloy based implant.
- the implant optionally has a hole bored through its longitudinal axis (a cannula) that allows for accurate placement into the sinus tarsi via a guide wire or guide peg.
- FIGURE 1 is a dorsal view of the bone structure of a human foot with a sinus tarsi implant in situ displaying the axis of rotation of the subtalar joint relative to the midline;
- FIGURE 2 is a lateral view of the bone structure of a human foot with an implant in situ displaying the axis of rotation of the subtalar joint relative to the horizontal plane;
- FIGURE 3 is a perspective view of a sinus tarsi implant in accordance with a preferred embodiment of the invention.
- FIGURE 4 is a side view of the sinus tarsi implant shown in Figure 3;
- FIGURE 5 is an end view of the sinus tarsi implant shown in Figure 3;
- FIGURE 6 is a cross-sectional view of the subject sinus tarsi implant taken along section line 6-6 in Figure 3;
- FIGURE 7 is a broken away view taken in the general direction of arrow "7" in Figure 2, of a left foot with a sinus tarsi implant in situ;
- FIGURE 8 is a broken away view taken in the general direction of arrow "8" in Figure 2, of a left foot with the talus removed to reveal the bottom half of the sinus tarsi and an implant in situ in accordance with the subject invention.
- FIGURE 9 is a broken away view of taken in the general direction of arrow "9" in Figure 2, of a left foot with the calcaneus removed to reveal the top half of the sinus tarsi with an implant in situ in a correct anatomical position.
- Figure 1 is a schematic representation of a patient's foot with a sinus tarsi implant 100 placed in accordance with a preferred embodiment of the invention. As described previously, the implant operates by arthroeresis (blocking of motion) of the patient's subtalar joint.
- the subtalar joint is the articulation between the talus 102 superiorly and the calcaneus 104 inferiorly.
- Figure 1 also illustrates an axis A-A of subtalar joint motion which is approximately 16 degrees measured from a midline axis B-B of a human foot.
- Figure 2 depicts the sinus tarsi implant 100, talus 102 and calcaneus
- Figure 3 illustrates a perspective view of an implant 100 comprising a first member 106 with an outer surface configuration generally in the shape of a frustum of a right cone.
- a frustum is the portion of a right circular cone lying between a circular cone base and a plane parallel to the base cutting off a top portion of the cone.
- a second member 108 is longitudinally attached to the frustum member 106 at the smaller end.
- the second member 108 is preferably a cylinder with a diameter substantially equal to the diameter of the small end of the frustum member 106.
- Figure 3 also discloses an optional third member 110 which is another cylindrical member having a diameter substantially equal to the diameter of the base of the frustum 106.
- Figure 4 is a side view of an implant that illustrates the specific members that make up an implant. The size and shape of these members are preferably determined as follows, the first member 106 is designed to sit on the lateral most aspect of the canalis tarsi. (The beginning or outermost aspect of the canalis tarsi. See Figures 7-9 described below.) In a preferred embodiment, the first member has an outer surface generally shaped as a right conical frustum.
- the second member 108 has an outer surface generally cylindrical in shape with an outer diameter approximately equal to that of the smaller end of the first (or frustum) member 106.
- Preferably fashioned about the outer surface of the second member is a series of one or more channels 112.
- the channeled surfaces are fashioned as a continuous thread.
- other tissue engagement surfaces are envisioned such as sinusoidal shapes or microporous cylindrical surfaces to promote interactions with connective tissue within the sinus tarsi.
- the second member 108 is designed to insert into the narrow, medial, portion of the sinus tarsi, the canalis tarsi. Note again Figures 7-9 below. [0042]
- the second member provides the important functions of anchoring the implant 100 in place and preventing collapse of the canalis tarsi canal.
- the channeling or threading serves to operably engage the surrounding soft tissue and ligaments and thus firmly and permanently anchors the implant in place.
- Anchoring the implant with channeling or threading is a significant improvement of prior art methods of anchoring. For example, other subtalar blocking implants were anchored by drilling a vertical hole in the dorsal aspect of the calcaneus that forms the floor of the sinus/outer portion of the sinus tarsi.
- the outer diameter of the second member 108 is selected to be large enough to prevent collapse of the canalis tarsi canal but not so large as to interfere with normal foot motion.
- a set of implants are provided having second member outer diameters ranging 0.6 cm to 1.1 cm in 0.10 cm increments. For this particular embodiment, the proper size is determined as explained below in Surgical Procedures and Instrumentation.
- An optional third member 110 is contemplated that extends out from the larger end of the first (or frustum) member 106 in the general shape of a cylinder. In other words, a cylindrical member 110 is axially connected to the base of the frustum 106. This portion of the implant is designed to rest in the outer most (lateral) region of implantation, sitting in the sinus portion of the sinus tarsi, note particularly Figure 8.
- the outer surface of member 110 can be modified to incorporate tissue engagement surfaces as described above.
- one or more peripheral channels 114 are fashioned into the outer surface of member 110 to permit fibrous tissue ingrowth.
- a plurality of two or more peripheral channels can be so fashioned.
- the third member 110 is generally not tapered. It has approximately the same outer diameter along its entire length as the base of the frustum 106. However, the third member can also have an outer surface with a slight degree of taper with the slightly larger diameter at the outermost aspect of the implant.
- the third member 110 functions (together with the first member) to block medial and anterior deviation of the talus. As a result, the implant blocks hyperpronation of the user's foot while at the same time allowing normal flexing of the user's foot.
- the third member 110 In order to properly block abnormal motion while allow normal motion, the third member 110 must have a carefully chosen outer diameter. In a preferred embodiment, a set of implants are provided having third member outer diameters ranging from 0.85 cm to 1.6 cm in 0.15 cm increments.
- Figure 5 illustrates a lateral end view of an implant. The lateral end is located at the frustum member base. Alternatively, if an optional third member is attached, the lateral end is at the free end of the third member. In a preferred embodiment, this end is provided with a recess having a selected geometric shape.
- Figure 5 illustrates a TORX shaped drive recess 118. The recess is configured to accept the end of an insertion tool having a complementary geometric shape.
- Figure 6 is a cross-sectional view of a preferred embodiment of the implant.
- Figure 6 reveals a cannula or longitudinal bore 116 traversing the entire length of the implant along a central longitudinal axis. The bore is fashioned to allow placement of the implant on a guide to facilitate proper surgical implantation. The implantation method is described below.
- FIG. 7 illustrates a left foot viewed from the front generally along line-of-sight "7" in Fig. 2.
- An implant 100 is shown together with cross-sections of both a left talus 102 and a left calcaneus 104.
- the implant is properly positioned when the frustum member abuts the lateral most aspect of the canalis tarsi.
- the lateral most aspect of the canalis tarsi is the region in which the canal narrows.
- Figure 7 illustrates that in the narrowing region an implant is in contact with the surrounding bone.
- Figure 7 also illustrates the second member in the deepest, or medial, end of the canal. The end of the second member is shown abutting the sulcus tali as explained above. Another method by which one insures proper positioning is to insert an implant until the end of the second member abuts the sulcus tali. This method can be used separately or together with the method above.
- Figure 8 illustrates in detail an implant 100 in situ viewed from above, generally along line-of-sight "8" in Figure 2. Revealed are the structures of the calcaneus 104 that define the bottom half of the sinus tarsi.
- the sinus tarsi is posterior to (behind) the talocalcaneonavicular joint which comprises the middle 120 and anterior talar facet 122 of the calcaneus 104.
- the sinus tarsi is anterior to (in front of) the subtalar joint which comprises the posterior talar facet 124 of the calcaneus 104.
- Figure 9 illustrates an implant 100 in situ viewed from below, generally along line-of-sight "9" in Figure 2.
- Figure 9 reveals the structures of the talus 102 that define the top half of the sinus tarsi. These structures are the complement of those illustrated in Figure 8.
- the sinus tarsi is posterior to (behind) the talocalcaneonavicular joint which comprises the middle 126 and anterior calcaneal facet of the talus 102.
- the sinus tarsi is anterior to (in front of) the subtalar joint which comprises the posterior calcaneal facet 128 of the talus 102.
- the subject invention is intended to provide a long term implant with expected useful life ranging from a period of years to a period of decades.
- the subject invention is intended to be operably a permanent implant; one that will rarely or preferably never require replacement over the lifetime of the user.
- the selected material of an implant 100 must be soft enough so as to prevent excessive wear and deformation of the surrounding bones causing undesirable side effects but, concomitantly, durable enough so that the implant itself will not excessively wear and deform and eventually fail or require premature replacement.
- an implant is made entirely from a single substance.
- the implant composition preferably comprises a medical grade polymer suitable for the insertion in the body in that it is substantially inert with respect to chemical reactions present in the body and is unlikely to result in adverse reactions, infections, adverse immunologic reactions such as allergic reactions or rejection.
- Still another preferred embodiment is a medical grade polymer suitable for long term or permanent implantation as defined above.
- the implant composition will comprise suitable polymers such as high molecular weight polyethylene, polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polymethyl-methacrylate (PMMA), polytetrafluoroethylene (PTFE), crystalline plastics, polyoxymethylene and DELRIN.
- suitable polymers such as high molecular weight polyethylene, polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polymethyl-methacrylate (PMMA), polytetrafluoroethylene (PTFE), crystalline plastics, polyoxymethylene and DELRIN.
- the implant composition need not be a single substance. Indeed it is envisioned that compositions comprising blends of two or more substances will be suitable. Suitable blends include combinations of polymer fibers dispersed in resins such as DELRIN AF, a blend of PTFE fibers uniformly dispersed in DELRIN acetal resin.
- post operative imaging fluoroscopic, magnetic resonance imaging, etc
- imaging may be desired for special purposes.
- an opaque structure can be imbedded into the implant or an opaque substance added to the polymer for the purposes of imaging.
- a "custom design” is envisioned where the exact size and shape is determined only after precise, detailed measurements of the inner dimensions of a patient's sinus tarsi.
- the generally cylindrical portions of the implant may be tapered or shaped if necessary; however, the general cylindrical configuration will remain.
- the first member, or generally frustum shaped portion may be concave or convex as appropriate; however, the general funnel configuration will remain. In effect, with the custom design method there are as many different shapes and sizes as there are patients.
- the custom design embodiment has advantages such as the patient receiving a precise amount of arthroeresic correction (degree of blocking of abnormal motion) which could be critical in special cases, for example elite athletes, dancers and others whose occupations place unusual stresses on this region.
- arthroeresic correction degree of blocking of abnormal motion
- the actual number of different sizes and shapes of implants to be manufactured will ultimately depend upon economic considerations. If cost is the predominant factor than a relatively small number of different sized and shaped implants will be manufactured. On the other hand, as precision fit becomes a more dominant factor, then the number of different sizes and shapes available will increase accordingly, perhaps to a very large number.
- the shape of the transition between the cylinder and frustum can also vary. This transition need not be abrupt as depicted, for example, in the implant 100 of Figure 4. (Note the relatively sharp transition edge between the optional third member 110 and the first member 106 and between the first member 106 and the second member 108). Rather, the transition could be smooth and gradual leaving no sharp "edge.”
- Instrumentation of this system includes a set of cannulated probing devices, a set of implants, a cannulated insertion tool and a guide wire or guide pin.
- the probing devices have a diameter ranging from 0.6 cm to 1.1 cm to correspond to the size implant required for correction. Each probing device is increased in diameter by 1 mm.
- the sinus tarsi implants are preferably provided in a set that range in size. Measuring from the outer diameter of narrow part of the implant (the second member) the set will, preferable, have a gauge from 0.6 cm to 1.1 cm. Implant size should, preferably, increase 1 mm in diameter from 0.6 cm to 1.1 cm.
- a cannulated insertion tool is also included to advance the implant into the sinus tarsi.
- the insertion tool functions much like a screw driver as described below.
- a preferred operative procedure consists of making a 1 cm to 2 cm linear incision over the sinus tarsi parallel to the relaxed skin tension lines. The incision is deepened via blunt dissection to the sinus tarsi.
- the proper angle along which the implant is inserted into the patients sinus tarsi is then determined with one of the probing devices.
- the 0.6 cm cannulated probing device is inserted into the sinus tarsi from lateral distal dorsal to medial proximal plantar until it is palpated exiting the medial aspect of the sinus tarsi.
- the angle of the probing device is the proper angle along which the implant is inserted.
- a guide (preferably a guide wire or a guide pin) is then inserted into the cannula of the probing device and is left in place until the end of the procedure.
- the implant 100 is cannulated (fashioned with a central longitudinal hole or cannula) 116 so that the implant can be placed on the guide followed by the cannulated insertion tool. Through the action of the insertion tool, the implant is then advanced into the sinus tarsi until proper placement is achieved. Correct placement of the implant occurs when the first member 106 abuts the lateral most aspect of the canalis tarsi. (The beginning or outermost aspect of the canalis tarsi.) See the middle members of the implants 100 in Figures 7-9.
- placement can be achieved when the second member 108 abuts the lateral aspect of the talus, the sulcus tali. See the end of the second member (the small member) of implant 100 in Figure 7.
- the implant is advanced into position by rotation.
- the implant can be rotated into position by use of any conventional method of applying torque, including the use of manual tools and power tools.
- the insertion tool is inserted into a recess on the lateral end of the implant and torque is applied.
- Another advantage is the long useful lifetime of the implant. When the implant is made of the correct material, it will neither wear the surrounding bones nor will the implant wear.
- a related advantage that also increases the lifetime of the implant is the permanent anchoring of the implant by way of the peripheral channels and threading. Failure due to slippage out of position will be rare or absent. Also, the surrounding bones remain strong as compared to procedures in which anchoring is achieved by drilling a hole into the calcaneus or the use of other invasive anchoring methods. As a result, complications stemming from weak surrounding bones are unlikely.
- a still further advantage of the implant system is the ability to accurately position the implant without irradiation.
- the implant is correctly positioned when the implant abuts the lateral most aspect of the canalis tarsi or the sulcus tali or both.
- a fluoroscope and irradiation of the user's foot to verify the positioning.
- Another advantage of the subject sinus tarsi implant is primary correction of hyperpronation, talipes valgus, pes planus, and other related rearfoot and forefoot deformities.
- the implant will also be used for secondary correction of growing pains, shin splints, posterior tibial tendon dysfunction, plantar fasciitis, hallux abductovalgus, metatarsus primus varus and elevatus, metatarsus adducts, contracted toes, abnormal gait, intermetarsal neuromas, as well as sciatica, patellofemoral pain, genu varum anterior pelvic tilt, lumbar lordosis, etc.
- another advantage is that the implant is inserted via a minimally invasive procedure and no casting is needed following the procedure so that there is a quick recovery.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE602004014543T DE602004014543D1 (en) | 2004-02-19 | 2004-11-04 | Tarsal sinus IMPLANT |
EP04810246A EP1755497B1 (en) | 2004-02-19 | 2004-11-04 | Sinus tarsi implant |
BRPI0418533A BRPI0418533B1 (en) | 2004-02-19 | 2004-11-04 | tarsal canal implants |
JP2006554083A JP4490447B2 (en) | 2004-02-19 | 2004-11-04 | Tarsal sinus implant |
AU2004316283A AU2004316283B2 (en) | 2004-02-19 | 2004-11-04 | Sinus tarsi implant |
CA002556930A CA2556930C (en) | 2004-02-19 | 2004-11-04 | Sinus tarsi implant |
DK04810246T DK1755497T3 (en) | 2004-02-19 | 2004-11-04 | Sinus Tarsi implant |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/780,872 | 2004-02-19 | ||
US10/780,872 US7033398B2 (en) | 2004-02-19 | 2004-02-19 | Sinus tarsi implant |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005081704A2 true WO2005081704A2 (en) | 2005-09-09 |
WO2005081704A3 WO2005081704A3 (en) | 2006-01-05 |
Family
ID=34860903
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/036557 WO2005081704A2 (en) | 2004-02-19 | 2004-11-04 | Sinus tarsi implant |
Country Status (12)
Country | Link |
---|---|
US (1) | US7033398B2 (en) |
EP (1) | EP1755497B1 (en) |
JP (1) | JP4490447B2 (en) |
AT (1) | ATE398429T1 (en) |
AU (1) | AU2004316283B2 (en) |
BR (1) | BRPI0418533B1 (en) |
CA (1) | CA2556930C (en) |
DE (1) | DE602004014543D1 (en) |
DK (1) | DK1755497T3 (en) |
ES (1) | ES2308293T3 (en) |
PT (1) | PT1755497E (en) |
WO (1) | WO2005081704A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012028920A3 (en) * | 2010-08-26 | 2012-05-24 | Giancarlo Guizzardi | Intervertebral support |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7235079B2 (en) * | 2004-11-18 | 2007-06-26 | Acumed Llc | Composite bone fasteners |
US20030078614A1 (en) * | 2001-10-18 | 2003-04-24 | Amr Salahieh | Vascular embolic filter devices and methods of use therefor |
US20060041315A1 (en) * | 2004-05-04 | 2006-02-23 | Biopro, Inc. | Subtalar implant |
US7678153B2 (en) * | 2004-05-04 | 2010-03-16 | Biopro, Inc. | Subtalar implant |
US20060190088A1 (en) * | 2005-02-23 | 2006-08-24 | Parks Brent G | Prosthesis for correction of flatfoot deformity |
HRP20050295B1 (en) * | 2005-03-29 | 2010-11-30 | Roth Sandor | The canulated titanium implant for correcting flat feet in children |
US8628582B2 (en) * | 2005-08-22 | 2014-01-14 | Vilex In Tennessee, Inc. | Subtalar implant and methods of use thereof |
FR2906999B1 (en) * | 2006-10-13 | 2009-06-05 | Tornier Sas | PROTHETIC SET OF ANKLE |
US20080208349A1 (en) * | 2007-02-23 | 2008-08-28 | Robert Graser | Expandable subtabar implant |
US20090099664A1 (en) * | 2007-10-16 | 2009-04-16 | Forrester Perry C | Subtalar implant and kit |
US8303589B2 (en) * | 2008-06-24 | 2012-11-06 | Extremity Medical Llc | Fixation system, an intramedullary fixation assembly and method of use |
US8313487B2 (en) * | 2008-06-24 | 2012-11-20 | Extremity Medical Llc | Fixation system, an intramedullary fixation assembly and method of use |
US8328806B2 (en) * | 2008-06-24 | 2012-12-11 | Extremity Medical, Llc | Fixation system, an intramedullary fixation assembly and method of use |
US9005301B2 (en) * | 2009-04-29 | 2015-04-14 | Foot Innovations, Llc | System and method for modifying talocalcaneal relationship in a foot |
US8574305B2 (en) | 2009-04-29 | 2013-11-05 | Foot Innovations, Llc | System and method for modifying talocalcaneal relationship in a foot |
US10092409B2 (en) * | 2010-02-24 | 2018-10-09 | Kent A. Feldman | Subtalar arthroereisis implant apparatus and treatment method |
US10856990B2 (en) * | 2010-02-24 | 2020-12-08 | Kent A. Feldman | Subtalar arthroereisis implant apparatus and treatment method |
US9498273B2 (en) | 2010-06-02 | 2016-11-22 | Wright Medical Technology, Inc. | Orthopedic implant kit |
US9724140B2 (en) | 2010-06-02 | 2017-08-08 | Wright Medical Technology, Inc. | Tapered, cylindrical cruciform hammer toe implant and method |
US9072564B2 (en) | 2010-06-02 | 2015-07-07 | Wright Medical Technology, Inc. | Hammer toe implant and method |
US8608785B2 (en) | 2010-06-02 | 2013-12-17 | Wright Medical Technology, Inc. | Hammer toe implant with expansion portion for retrograde approach |
US8636808B2 (en) | 2011-01-21 | 2014-01-28 | Trilliant Surgical, Ltd. | Spherical subtalar implant |
RU2470605C2 (en) * | 2011-04-06 | 2012-12-27 | Федеральное государственное учреждение "Нижегородский научно-исследовательский институт травматологии и ортопедии" Министерства здравоохранения и социального развития Российской Федерации | Implant for stabilisation of subtalar joint |
WO2013025702A1 (en) * | 2011-08-16 | 2013-02-21 | Osteospring Medical, Inc. | Wedge shaped fracture fixation devices and methods for using the same |
US8945232B2 (en) | 2012-12-31 | 2015-02-03 | Wright Medical Technology, Inc. | Ball and socket implants for correction of hammer toes and claw toes |
CN104337591A (en) * | 2013-08-02 | 2015-02-11 | 迈克尔·格莱汉姆 | Tarsal-sinus implantation material |
US9724139B2 (en) | 2013-10-01 | 2017-08-08 | Wright Medical Technology, Inc. | Hammer toe implant and method |
US9474561B2 (en) | 2013-11-19 | 2016-10-25 | Wright Medical Technology, Inc. | Two-wire technique for installing hammertoe implant |
US9498266B2 (en) | 2014-02-12 | 2016-11-22 | Wright Medical Technology, Inc. | Intramedullary implant, system, and method for inserting an implant into a bone |
US9545274B2 (en) | 2014-02-12 | 2017-01-17 | Wright Medical Technology, Inc. | Intramedullary implant, system, and method for inserting an implant into a bone |
FR3021864B1 (en) * | 2014-06-06 | 2019-10-25 | In2Bones | SURGICAL IMPLANT, IMPLEMENT TOOL, SURGICAL KIT AND METHOD FOR MANUFACTURING THE SAME |
US9808296B2 (en) | 2014-09-18 | 2017-11-07 | Wright Medical Technology, Inc. | Hammertoe implant and instrument |
EP3232960A4 (en) | 2014-12-19 | 2018-08-15 | Wright Medical Technology, Inc. | Intramedullary anchor for interphalangeal arthrodesis |
US10980617B2 (en) * | 2015-02-23 | 2021-04-20 | Maurice Valen | Implantable surgical screw for bone reconstruction |
US9943414B2 (en) | 2015-12-30 | 2018-04-17 | Wasas, Llc. | System and method for non-binding allograft subtalar joint implant |
US20210128313A1 (en) * | 2016-02-04 | 2021-05-06 | Michael Graham | Sinus tarsi implant |
FR3069430B1 (en) * | 2017-07-25 | 2023-03-31 | Neosteo | SUBTALIAN IMPLANT FOR ARTHROSIS OF THE TALO-CALCANEAL JOINT |
EP3735193A1 (en) | 2018-01-03 | 2020-11-11 | GLW, Inc. | Hybrid cannulated orthopedic screws |
US11628000B2 (en) | 2019-03-18 | 2023-04-18 | Glw, Inc. | Hybrid bone plate |
CN111529142A (en) * | 2020-04-17 | 2020-08-14 | 蒋青 | Talus prosthesis model for 3D printing and forming method of talus prosthesis by 3D printing |
RU2752712C1 (en) * | 2020-10-13 | 2021-07-30 | Общество с ограниченной ответственностью "Научно-производственная компания "СИНТЕЛ" | Implant for subtalar arthroereisis |
RU2767897C1 (en) * | 2021-04-06 | 2022-03-22 | Общество с ограниченной ответственностью "Научно-производственная компания "СИНТЕЛ" | Set of tools for subtalar arthroeresis |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4450591A (en) * | 1981-12-10 | 1984-05-29 | Rappaport Mark J | Internal anti-proratory plug assembly and process of installing the same |
US4453821A (en) * | 1982-04-01 | 1984-06-12 | Eastman Kodak Company | Set-up recall apparatus |
FR2543821A3 (en) * | 1983-04-08 | 1984-10-12 | Viladot Perice Antonio | Endo-orthesis for flat feet |
SE8903403D0 (en) * | 1989-10-16 | 1989-10-16 | Sven Olerud | DEVICE FOR FIXING INSTRUMENTS FOR BACKGROUND OPERATIONS |
FR2682281B1 (en) * | 1991-10-11 | 1997-01-03 | Sofamor | PERCUTANEOUS SCREW, INTENDED TO SUPPORT IN PARTICULAR A STEREOTAXY FRAMEWORK |
IT228979Y1 (en) * | 1992-03-09 | 1998-06-05 | Giannini Sandro | BIODEGRADABLE PROSTHESIS FOR READY FOOT CORRECTION. |
SE507336C2 (en) * | 1995-10-12 | 1998-05-18 | Nobel Biocare Ab | Holder for bone implantation |
US6168631B1 (en) | 1997-08-29 | 2001-01-02 | Kinetikos Medical, Inc. | Subtalar implant system and method for insertion and removal |
FR2782913B1 (en) | 1998-09-04 | 2000-11-10 | Perice Ramon Viladot | IMPLANT FOR FLAT FOOT |
US6607535B1 (en) * | 1999-02-04 | 2003-08-19 | Kwan-Ho Chan | Universal bone cement plug and method of use |
US6443954B1 (en) * | 2001-04-24 | 2002-09-03 | Dale G. Bramlet | Femoral nail intramedullary system |
US8092547B2 (en) * | 2004-02-10 | 2012-01-10 | Tornier, Inc. | Subtalar implant assembly |
US8628581B2 (en) * | 2004-02-11 | 2014-01-14 | Osteomed Llc | Conical, threaded subtalar implant |
-
2004
- 2004-02-19 US US10/780,872 patent/US7033398B2/en not_active Expired - Lifetime
- 2004-11-04 EP EP04810246A patent/EP1755497B1/en active Active
- 2004-11-04 PT PT04810246T patent/PT1755497E/en unknown
- 2004-11-04 WO PCT/US2004/036557 patent/WO2005081704A2/en active Application Filing
- 2004-11-04 CA CA002556930A patent/CA2556930C/en active Active
- 2004-11-04 DE DE602004014543T patent/DE602004014543D1/en active Active
- 2004-11-04 ES ES04810246T patent/ES2308293T3/en active Active
- 2004-11-04 BR BRPI0418533A patent/BRPI0418533B1/en not_active IP Right Cessation
- 2004-11-04 DK DK04810246T patent/DK1755497T3/en active
- 2004-11-04 JP JP2006554083A patent/JP4490447B2/en not_active Expired - Fee Related
- 2004-11-04 AT AT04810246T patent/ATE398429T1/en active
- 2004-11-04 AU AU2004316283A patent/AU2004316283B2/en active Active
Non-Patent Citations (1)
Title |
---|
See references of EP1755497A4 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2012028920A3 (en) * | 2010-08-26 | 2012-05-24 | Giancarlo Guizzardi | Intervertebral support |
US9820863B2 (en) | 2010-08-26 | 2017-11-21 | Giancarlo Guizzardi | Intervertebral support |
Also Published As
Publication number | Publication date |
---|---|
EP1755497B1 (en) | 2008-06-18 |
CA2556930A1 (en) | 2005-09-09 |
JP2007522871A (en) | 2007-08-16 |
PT1755497E (en) | 2008-08-11 |
BRPI0418533B1 (en) | 2015-11-03 |
US7033398B2 (en) | 2006-04-25 |
CA2556930C (en) | 2010-01-12 |
EP1755497A2 (en) | 2007-02-28 |
BRPI0418533A (en) | 2007-05-15 |
WO2005081704A3 (en) | 2006-01-05 |
EP1755497A4 (en) | 2007-10-10 |
US20050187636A1 (en) | 2005-08-25 |
DE602004014543D1 (en) | 2008-07-31 |
ES2308293T3 (en) | 2008-12-01 |
AU2004316283A1 (en) | 2005-09-09 |
ATE398429T1 (en) | 2008-07-15 |
JP4490447B2 (en) | 2010-06-23 |
DK1755497T3 (en) | 2008-10-20 |
AU2004316283B2 (en) | 2009-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7033398B2 (en) | Sinus tarsi implant | |
US11179234B2 (en) | Ligament fixation system, implants, devices, and methods of use | |
US20130131821A1 (en) | Catheter deliverable foot implant and method of delivering the same | |
US20070142920A1 (en) | Metatarsal implant | |
CN102438555A (en) | Systems and methods for facet joint treatment | |
CA2732793A1 (en) | Fixation and alignment device and method used in orthopaedic surgery | |
Johnson et al. | Total Replacement Arthroplasty of the First Metatarsophalangeal Joint∗ | |
US10772733B2 (en) | Implants and methods of use and assembly | |
US11911281B2 (en) | Implants, systems, and methods of use and assembly | |
US11273045B2 (en) | Motion toe systems and methods | |
Axt et al. | Late results of the Keller-Brandes operation for hallux valgus | |
Wiewiorski et al. | Painful flatfoot deformity | |
EP3027146B1 (en) | Improved sinus tarsi implant | |
US20210128313A1 (en) | Sinus tarsi implant | |
EP3592265B1 (en) | Bone implant devices | |
US20130006379A1 (en) | Talar-calcaneal sinus-canalis internal-fixation device | |
US20170224382A1 (en) | Sinus tarsi implant | |
US11278419B2 (en) | Expandable subtalar joint implant and insertion device | |
BR102016003921A2 (en) | TARSE IMPLANT | |
WO2019055923A1 (en) | Ligament fixation system, implants, devices, and methods of use | |
Mehta et al. | Arthritis of the Ankle | |
Barouk et al. | Some Pathologies of the Fifth Ray |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006554083 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2556930 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004316283 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004810246 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2004316283 Country of ref document: AU Date of ref document: 20041104 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004316283 Country of ref document: AU |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2004810246 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: PI0418533 Country of ref document: BR |